Skip to main content
Clinical Trials/NCT02526602
NCT02526602
Completed
Not Applicable

Preservation of Endopelvic Fascia During Radical Prostatectomy: Effects on Postoperative Incontinence and Impotence. Randomized Clinical Trial.

Tampere University Hospital1 site in 1 country158 target enrollmentAugust 2015

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Prostatic Neoplasms
Sponsor
Tampere University Hospital
Enrollment
158
Locations
1
Primary Endpoint
Erectile function
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

Urinary incontinence and impotence are typical disturbances after radical prostatectomy. Although, several surgical methods are developed to decrease these disturbances, 8% and 50% of the patients suffer from permanent urinary incontinence and impotence, respectively.

Previously two studies have shown that endopelvic fascia preservation may decrease postoperative incontinence and impotence rates. Unfortunately these studies are retrospective decreasing their reliability.

The present study is prospective and randomized clinical trial. The investigators are going to randomize 180 patient to preservation and opening the endopelvic fascia groups. Functional and oncological results are followed up to 1 year after surgery.

Detailed Description

180 patients going to radical prostatectomy as treatment of prostate cancer will be randomized 1:1 to two study arms: In the other arm endopelvic fascia are preserved during the operation, in the other arm the fascia are opened. After the operation urinary continence and erection function are compared between the study arms. Additionally the investigators will study oncological outcomes.

Registry
clinicaltrials.gov
Start Date
August 2015
End Date
September 2019
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Male

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Localized prostate cancer
  • Planned nerve-sparing robotic radical prostatectomy
  • Gleason score 7 or less

Exclusion Criteria

  • Previous prostate surgery (TURP, TUIP, laser...)
  • Planned lymphadenectomy
  • T3 cancer

Outcomes

Primary Outcomes

Erectile function

Time Frame: 1 year

EPIC-26 questionnaire preoperatively and 3 and 12 months after surgery

Urinary incontinence

Time Frame: 1 year

EPIC-26 questionnaire preoperatively and 3 and 12 months after surgery

Secondary Outcomes

  • Complications(1 year)
  • Oncologic results: positive surgical margin rate(1 year)

Study Sites (1)

Loading locations...

Similar Trials